Nasal Monoclonal Antibody Suppresses Inflammatory Response in COVID-19
![](https://www.brighamhealthonamission.org/wp-content/uploads/2023/06/antibody-visual-concept-1-1.jpg)
In a new study, a Brigham team determined how nasal foralumab modulates inflammation and describes a potential novel avenue for treating not just COVID-19 but also autoimmune diseases.
Read More...